Dynamics in Post-pandemic Global Pediatric Drugs Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ662241
Publisher: Date of Publish:
No. of Pages: 165 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Pediatric Drugs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Pediatric Drugs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Allergy and Respiratory Drugs Anti-Infectives Cancer Therapies Cardiovascular Drugs Central Nervous System Drugs Gastrointestinal Drugs Hormone Drugs Urological Drugs Segmented by End User/Segment Hospital Clinic Drugstore Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Schering-Plough Roche Pharmacia Pfizer Novo Nordisk Novartis Pharmaceuticals Merck MedImmune Johnson & Johnson GlaxoSmithKline Genentech Forest Laboratories Eli Lilly Colgate Oral Pharmaceuticals Bristol-Myers Squibb Boehringer Ingelheim Bayer Abbott Laboratories
Table of Contents 1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Pediatric Drugs Market Status and Forecast (2016-2027) 1.3.2 Global Pediatric Drugs Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis 2 Global Pediatric Drugs Supply by Company 2.1 Global Pediatric Drugs Sales Volume by Company 2.2 Global Pediatric Drugs Sales Value by Company 2.3 Global Pediatric Drugs Price by Company 2.4 Pediatric Drugs Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate 3 Global and Regional Pediatric Drugs Market Status by Category 3.1 Pediatric Drugs Category Introduction 3.1.1 Allergy and Respiratory Drugs 3.1.2 Anti-Infectives 3.1.3 Cancer Therapies 3.1.4 Cardiovascular Drugs 3.1.5 Central Nervous System Drugs 3.1.6 Gastrointestinal Drugs 3.1.7 Hormone Drugs 3.1.8 Urological Drugs 3.2 Global Pediatric Drugs Market by Category 3.2.1 Global Pediatric Drugs Sales Volume by Category (2016-2021) 3.2.2 Global Pediatric Drugs Sales Value by Category (2016-2021) 3.2.3 Global Pediatric Drugs Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category 4 Global and Regional Pediatric Drugs Market Status by End User/Segment 4.1 Pediatric Drugs Segment by End User/Segment 4.1.1 Hospital 4.1.2 Clinic 4.1.3 Drugstore 4.2 Global Pediatric Drugs Market by End User/Segment 4.2.1 Global Pediatric Drugs Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Pediatric Drugs Sales Value by End User/Segment (2016-2021) 4.2.3 Global Pediatric Drugs Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment 5 Global Pediatric Drugs Market Status by Region 5.1 Global Pediatric Drugs Market by Region 5.1.1 Global Pediatric Drugs Sales Volume by Region 5.1.2 Global Pediatric Drugs Sales Value by Region 5.2 North America Pediatric Drugs Market Status 5.3 Europe Pediatric Drugs Market Status 5.4 Asia Pacific Pediatric Drugs Market Status 5.5 Central & South America Pediatric Drugs Market Status 5.6 Middle East & Africa Pediatric Drugs Market Status 6 North America Pediatric Drugs Market Status 6.1 North America Pediatric Drugs Market by Country 6.1.1 North America Pediatric Drugs Sales Volume by Country (2016-2021) 6.1.2 North America Pediatric Drugs Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico 7 Europe Pediatric Drugs Market Status 7.1 Europe Pediatric Drugs Market by Country 7.1.1 Europe Pediatric Drugs Sales Volume by Country (2016-2021) 7.1.2 Europe Pediatric Drugs Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain 8 Asia Pacific Pediatric Drugs Market Status 8.1 Asia Pacific Pediatric Drugs Market by Country 8.1.1 Asia Pacific Pediatric Drugs Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Pediatric Drugs Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia 9 Central & South America Pediatric Drugs Market Status 9.1 Central & South America Pediatric Drugs Market by Country 9.1.1 Central & South America Pediatric Drugs Sales Volume by Country (2016-2021) 9.1.2 Central & South America Pediatric Drugs Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia 10 Middle East & Africa Pediatric Drugs Market Status 10.1 Middle East & Africa Pediatric Drugs Market by Country 10.1.1 Middle East & Africa Pediatric Drugs Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Pediatric Drugs Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia 11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Pediatric Drugs Manufacturing Cost Analysis 11.5 Pediatric Drugs Sales Channel and Distributors Analysis 11.5.1 Pediatric Drugs Sales Channel 11.5.2 Pediatric Drugs Distributors 11.6 Pediatric Drugs Downstream Major Buyers 12 Global Pediatric Drugs Market Forecast by Category and by End User/Segment 12.1 Global Pediatric Drugs Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Pediatric Drugs Forecast by Category 12.2.1 Global Pediatric Drugs Sales Volume Forecast by Category 12.2.2 Global Pediatric Drugs Sales Value Forecast by Category 12.2.3 Global Pediatric Drugs Price Forecast by Category 12.3 Global Pediatric Drugs Forecast by End User/Segment 12.3.1 Global Pediatric Drugs Sales Volume Forecast by End User/Segment 12.3.2 Global Pediatric Drugs Sales Value Forecast by End User/Segment 12.3.3 Global Pediatric Drugs Price Forecast by End User/Segment 13 Global Pediatric Drugs Market Forecast by Region/Country 13.1 Global Pediatric Drugs Market Forecast by Region (2022-2027) 13.1.1 Global Pediatric Drugs Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Pediatric Drugs Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast 14 Key Participants Company Information 14.1 Schering-Plough 14.1.1 Company Information 14.1.2 Pediatric Drugs Product Introduction 14.1.3 Schering-Plough Pediatric Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Roche 14.2.1 Company Information 14.2.2 Pediatric Drugs Product Introduction 14.2.3 Roche Pediatric Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Pharmacia 14.3.1 Company Information 14.3.2 Pediatric Drugs Product Introduction 14.3.3 Pharmacia Pediatric Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Pfizer 14.4.1 Company Information 14.4.2 Pediatric Drugs Product Introduction 14.4.3 Pfizer Pediatric Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Novo Nordisk 14.5.1 Company Information 14.5.2 Pediatric Drugs Product Introduction 14.5.3 Novo Nordisk Pediatric Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Novartis Pharmaceuticals 14.6.1 Company Information 14.6.2 Pediatric Drugs Product Introduction 14.6.3 Novartis Pharmaceuticals Pediatric Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Merck 14.7.1 Company Information 14.7.2 Pediatric Drugs Product Introduction 14.7.3 Merck Pediatric Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 MedImmune 14.8.1 Company Information 14.8.2 Pediatric Drugs Product Introduction 14.8.3 MedImmune Pediatric Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Johnson & Johnson 14.9.1 Company Information 14.9.2 Pediatric Drugs Product Introduction 14.9.3 Johnson & Johnson Pediatric Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 GlaxoSmithKline 14.10.1 Company Information 14.10.2 Pediatric Drugs Product Introduction 14.10.3 GlaxoSmithKline Pediatric Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis 14.11 Genentech 14.12 Forest Laboratories 14.13 Eli Lilly 14.14 Colgate Oral Pharmaceuticals 14.15 Bristol-Myers Squibb 14.16 Boehringer Ingelheim 14.17 Bayer 14.18 Abbott Laboratories 15 Conclusion 16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com